Cost-Benefit Assessment of Antifungal Prophylaxis with Liposomal Amphotericin B in Neutropenic Patients

Publisher： Karger

E-ISSN： 2296-5262|30|12|621-626

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.30, Iss.12, 2007-11, pp. : 621-626

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antifungal prophylaxis with itraconazole oral solution in neutropenic patients

By  

MYCOSES (ELECTRONIC), Vol. 42, Iss. S2, 1999-12 ,pp. : 121-124

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early empiric antifungal therapy of infections in neutropenic patients comparing fluconazole with amphotericin B/flucytosine

By  

MYCOSES (ELECTRONIC), Vol. 42, Iss. S2, 1999-12 ,pp. : 101-104

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and Efficacy of Itraconazole Compared to Amphotericin B as Empirical Antifungal Therapy for Neutropenic Fever in Patients with Haematological Malignancy*

By  

Oncology Research and Treatment, Vol. 30, Iss. 4, 2007-03 ,pp. : 185-191

Karger

Access to resources Recommend Favorite

Haemopoietic Cell Transplantation of Patients with a History of Deep or Invasive Fungal Infection during Prophylaxis with Liposomal Amphotericin B

By  

Acta Haematologica, Vol. 113, Iss. 2, 2005-03 ,pp. : 104-108

Karger

Access to resources Recommend Favorite

Economic evaluation of caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia in Sweden

By Naik Shalini   Lundberg Johan   Kumar Ritesh   Sjolin Jan   Jansen Jeroen P.  

Scandinavian Journal of Infectious Diseases, Vol. 43, Iss. 6-7, 2011-07 ,pp. : 504-514

Informa Healthcare

Access to resources Recommend Favorite